MiR-34c attenuates epithelial-mesenchymal transition and kidney fibrosis with ureteral obstruction

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Morizane, Ryuji ^a   Fujii, Shizuka ^a   Monkawa, Toshiaki ^a   Hiratsuka, Ken ^a   Yamaguchi, Shintaro ^a   Homma, Koichiro ^a   Itoh, Hiroshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTA2 PROTEIN, MOUSE; ACTIN; ANTISENSE OLIGONUCLEOTIDE; CALCIUM BINDING PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; MEMBRANE PROTEIN; MICRORNA; SERRATE PROTEINS; SIGNAL PEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSIS; GENETICS; KIDNEY; METABOLISM; MOUSE; PATHOLOGY; URETER OBSTRUCTION;

ACTINS; ANIMALS; CALCIUM-BINDING PROTEINS; CELL LINE; COLLAGEN TYPE I; COLLAGEN TYPE III; CONNECTIVE TISSUE GROWTH FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; FIBRONECTINS; FIBROSIS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MEMBRANE PROTEINS; MICE; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; TRANSFORMING GROWTH FACTOR BETA; URETERAL OBSTRUCTION;

EID: 84897527865     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04578     Document Type: Article

References (60)

1. Benfey, P. N. Molecular biology: microRNA is here to stay. Nature 425, 244-245; DOI:10.1038/425244a (2003). (Pubitemid 37158385)
2. Hurst, D. R., Edmonds, M. D. & Welch, D. R. Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 69, 7495-7498; DOI:10.1158/0008-5472.CAN-09-2111 (2009).
3. Liu, Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21, 212-222; DOI:10.1681/ASN.2008121226 (2010).
4. Sharma, K. et al. Pirfenidone for diabetic nephropathy. J Am Soc Nephrol 22, 1144-1151; DOI:10.1681/ASN.2010101049 (2011).
5. Decleves, A. E. & Sharma, K. New pharmacological treatments for improving renal outcomes in diabetes. Nat Rev Nephrol 6, 371-380; DOI:10.1038/nrneph.2010.57 (2010).
6. Sato, M., Muragaki, Y., Saika, S., Roberts, A. B. & Ooshima, A. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112, 1486-1494; DOI:10.1172/JCI19270 (2003). (Pubitemid 38056275)
7. Yoshino, J. et al. Snail1 is involved in the renal epithelial-mesenchymal transition. Biochem Biophys Res Commun 362, 63-68; DOI:10.1016/j.bbrc.2007.07. 146 (2007). (Pubitemid 47296293)
8. Lebleu, V. S. et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19, 1047-1053; DOI:10.1038/nm.3218 (2013).
9. Bielesz, B. et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 120, 4040-4054; DOI:10.1172/JCI43025 (2010).
10. Boutet, A. et al. Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 25, 5603-5613; DOI:10.1038/sj. emboj.7601421 (2006). (Pubitemid 44847200)
11. Lorenzen, J. M., Haller, H. & Thum, T. MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol 7, 286-294; DOI:10.1038/nrneph.2011.26 (2011).
12. Ho, J. et al. Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol 19, 2069-2075; DOI:10.1681/ASN.2008020162 (2008).
13. Wei, Q. et al. Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 21, 756-761; DOI:10.1681/ASN.2009070718 (2010).
14. Kato, M. TGF-beta-induced signaling circuit loops mediated by microRNAs as new therapeutic targets for renal fibrosis? Kidney Int 84, 1067-1069; DOI:10.1038/ki.2013.297 (2013).
15. Wu, J. et al. Downregulation of MicroRNA-30 Facilitates Podocyte Injury and Is Prevented by Glucocorticoids. J Am Soc Nephrol 25, 92-104; DOI:10.1681/ASN.2012111101 (2014).
16. Krebs, C. F. et al. MicroRNA-155 drives TH17 immune response and tissue injury in experimental crescentic GN. J Am Soc Nephrol 24, 1955-1965; DOI:10.1681/ASN.2013020130 (2013).
17. Srivastava, S. P., Koya, D. & Kanasaki, K. MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT. Biomed Res Int 2013, 125469; DOI:10.1155/2013/125469 (2013).
18. Chung, A. C., Huang, X. R., Meng, X. & Lan, H. Y. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol 21, 1317-1325; DOI:10.1681/ASN.2010020134 (2010).
19. Kriegel, A. J. et al. MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor beta 1: a novel role of miR-382. Nucleic Acids Res 38, 8338-8347; DOI:10.1093/nar/gkq718 (2010).
20. Krupa, A. et al. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 21, 438-447; DOI:10.1681/ASN.2009050530 (2010).
21. Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10, 593-601; DOI:10.1038/ncb1722 (2008). (Pubitemid 351627379)
22. Korpal, M., Lee, E. S., Hu, G. & Kang, Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283, 14910-14914; DOI:10.1074/jbc.C800074200 (2008).
23. Park, S. M., Gaur, A. B., Lengyel, E. & Peter, M. E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22, 894-907; DOI:10.1101/gad. 1640608 (2008). (Pubitemid 351482843)
24. Chandrasekaran, K. et al. Role of microRNAs in kidney homeostasis and disease. Kidney Int 81, 617-627; DOI:10.1038/ki.2011.448 (2012).
25. Xiong, M. et al. The miR-200 family regulates TGF-beta1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol 302, F369-379; DOI:10.1152/ajprenal.00268.2011 (2012).
26. Denby, L. et al. miR-21 and miR-214 are consistently modulated during renal injury in rodent models. Am J Pathol 179, 661-672; DOI:10.1016/j.ajpath. 2011.04.021 (2011).
27. Zhong, X., Chung, A. C., Chen, H. Y., Meng, X. M. & Lan, H. Y. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 22, 1668-1681; DOI:10.1681/ASN.2010111168 (2011).
28. Zhou, Y. et al. miR-21-containing microvesicles from injured tubular epithelial cells promote tubular phenotype transition by targeting PTEN protein. Am J Pathol 183, 1183-1196; DOI:10.1016/j.ajpath.2013.06.032 (2013).
29. Denby, L. et al. MicroRNA-214 antagonism protects against renal fibrosis. J Am Soc Nephrol 25, 65-80; DOI:10.1681/ASN.2013010072 (2014).
30. Inoue, T. et al. Fibroblast expression of an IkappaB dominant-negative transgene attenuates renal fibrosis. J Am Soc Nephrol 21, 2047-2052; DOI:10.1681/ASN.2010010003 (2010).
31. Yamaguchi, S. et al. The role of microRNA-145 in human embryonic stem cell differentiation into vascular cells. Atherosclerosis 219, 468-474; DOI:10.1016/j.atherosclerosis.2011.09.004 (2011).
32. Morizane, R., Monkawa, T. & Itoh, H. Differentiation of murine embryonic stem and induced pluripotent stem cells to renal lineage in vitro. Biochem Biophys Res Commun 390, 1334-1339; DOI:10.1016/j.bbrc.2009.10.148 (2009).
33. Morizane, R. et al. Kidney specific protein-positive cells derived from embryonic stem cells reproduce tubular structures in vitro and differentiate into renal tubular cells. PLoS One 8, e64843; DOI:10.1371/journal.pone.0064843 (2013).
34. Hermeking, H. The miR-34 family in cancer and apoptosis. Cell Death Differ 17, 193-199; DOI:10.1038/cdd.2009.56 (2010).
35. Corney, D. C., Flesken-Nikitin, A., Godwin, A. K., Wang, W. & Nikitin, A. Y. MicroRNA-34b and MicroRNA-34c are targetsofp53 and cooperateincontrol of cell proliferation and adhesion-independent growth. Cancer Res 67, 8433-8438; DOI:10.1158/0008-5472.CAN-07-1585 (2007). (Pubitemid 47437414)
36. Cardinaud, B. et al. miR-34b/miR-34c: a regulator of TCL1 expression in 11q-chronic lymphocytic leukaemia? Leukemia 23, 2174-2177; DOI:10.1038/leu.2009. 125 (2009).
37. Bae, Y. et al. miRNA-34c regulates Notch signaling during bone development. Hum Mol Genet 21, 2991-3000; DOI:10.1093/hmg/dds129 (2012).
38. Zavadil, J. & Bottinger, E. P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24, 5764-5774; DOI:10.1038/sj.onc.1208927 (2005). (Pubitemid 43086136)
39. Humphreys, B. D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176, 85-97; DOI:10.2353/ajpath.2010.090517 (2010).
40. He, X., He, L. & Hannon, G. J. The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res 67, 11099-11101; DOI:10.1158/0008-5472.CAN-07-2672 (2007). (Pubitemid 350248530)
41. Kumamoto, K. et al. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Cancer Res 68, 3193-3203; DOI:10.1158/0008-5472.CAN-07- 2780 (2008).
42. Antonini, D. et al. Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells. J Invest Dermatol 130, 1249-1257; DOI:10.1038/jid.2009.438 (2010).
43. Migliore, C. et al. MicroRNAs impair MET-mediated invasive growth. Cancer Res 68, 10128-10136; DOI:10.1158/0008-5472.CAN-08-2148 (2008).
44. Cai, K. M.et al. Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met. Int J Mol Med 25, 565-571; DOI: doi:10.3892/ijmm-00000378 (2010).
45. Liu, X. et al. Uncovering growth-suppressive MicroRNAs in lung cancer. Clin Cancer Res 15, 1177-1183; DOI:10.1158/1078-0432.CCR-08-1355 (2009).
46. Sempere, L. F., Liu, X. & Dmitrovsky, E. Tumor-suppressive microRNAs in Lung cancer: diagnostic and therapeutic opportunities. ScientificWorldJournal 9, 626-628; DOI:10.1100/tsw.2009.88 (2009).
47. Hagman, Z. et al. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions. Int J Cancer 127, 2768-2776; DOI:10.1002/ijc.25269 (2010).
48. Cannell, I. G. & Bushell, M. Regulation of Myc by miR-34c: A mechanism to prevent genomic instability? Cell Cycle 9, 2726-2730; DOI: 10.4161/cc.9.14.12182 (2010).
49. Cannell, I. G. et al. p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. Proc Natl Acad Sci U S A 107, 5375-5380; DOI:10.1073/pnas.0910015107 (2010).
50. Bouhallier, F. et al. Role of miR-34c microRNA in the late steps of spermatogenesis. RNA 16, 720-731; DOI:10.1261/rna.1963810 (2010).
51. Liang, X.et al. MicroRNA-34c enhances murine male germ cell apoptosis through targeting ATF1. PLoS One 7, e33861; DOI:10.1371/journal.pone.0033861 (2012).
52. Li, W. Q. et al. The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J 278, 1522-1532; DOI:10.1111/j.1742-4658.2011.08075.x (2011).
53. Yu, F. etal. MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells. J Biol Chem 287, 465-473; DOI:10.1074/jbc.M111.280768 (2012).
54. Lujambio, A. et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 105, 13556-13561; DOI:10.1073/pnas. 0803055105 (2008).
55. Kong, Y. W.etal. The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene. Proc Natl Acad Sci U S A 105, 8866-8871; DOI:10.1073/pnas.0800650105 (2008).
56. Nyhan, K. C. et al. Jagged/Notch signalling is required for a subset of TGFbeta1 responses in human kidney epithelial cells. Biochim Biophys Acta 1803, 1386-1395; DOI:10.1016/j.bbamcr.2010.09.001 (2010).
57. Okada, H., Danoff, T. M., Kalluri, R. & Neilson, E. G. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 273, F563-574 (1997).
58. Matsuyama, M. et al. Defect of mitotic vimentin phosphorylation causes microophthalmia and cataract via aneuploidy and senescence in lens epithelial cells. J Biol Chem 288, 35626-35635; DOI:10.1074/jbc.M113.514737 (2013).
59. Steg, A. D. et al. Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer. Clin Cancer Res 17, 5674-5685; DOI:10.1158/1078-0432.CCR-11-0432 (2011).
60. Lacor, P. N. et al. Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation. Proc Natl Acad Sci U S A 97, 3556-3561; DOI:10.1073/pnas.050589597 (2000). (Pubitemid 30183341)